Learn About TB Testing Methods and Options

Understanding Tuberculosis Testing: Why It Matters

Tuberculosis (TB) is an infection caused by bacteria called Mycobacterium tuberculosis. According to the World Health Organization, approximately 10 million people develop active TB disease each year worldwide, with about 1.3 million TB-related deaths annually. In the United States, the Centers for Disease Control and Prevention (CDC) reported about 7,400 TB cases in 2022. Understanding TB testing is important because early detection can prevent serious illness and stop the spread of infection to others.

TB exists in two forms: latent TB infection and active TB disease. When someone has latent TB infection, the bacteria are present in their body but dormant, meaning they don't feel sick and can't spread the disease to others. However, without treatment, latent TB can progress to active disease. Active TB disease causes symptoms like persistent cough, chest pain, fever, chills, and fatigue. Testing helps identify both forms so that appropriate treatment can begin.

People at higher risk of TB infection include those who have close contact with someone with active TB, people living with HIV, those with weakened immune systems, and individuals from countries where TB is more common. Healthcare workers, incarcerated individuals, and people experiencing homelessness also face elevated risk. Testing is often recommended for these groups to catch infections before they become serious.

The good news is that TB is treatable with antibiotics, and modern testing methods are reliable and relatively quick. This guide explores the different ways doctors can test for TB, what to expect during testing, and how results are interpreted. Understanding these options helps people make informed decisions about their health.

Practical Takeaway: TB testing is recommended for people with symptoms or risk factors. Knowing what testing methods exist helps you discuss options with your healthcare provider.

The Tuberculin Skin Test (TST): How It Works

The Tuberculin Skin Test, also called the Mantoux test or intradermal test, has been used for over a century to detect TB infection. During this test, a healthcare provider injects a small amount of purified protein derivative (PPD) into the skin on the inner forearm. The injection creates a small bump or blister on the skin's surface, but it's painless or causes only mild discomfort—many people describe it as feeling like a mosquito bite.

After the injection, the person must return to the testing location 48 to 72 hours later. At this follow-up visit, a healthcare provider examines the injection site and measures any swelling or induration (hardened area) that developed. This measurement, done in millimeters, determines whether the test result is positive, negative, or uncertain. The size of the swelling indicates the likelihood of TB infection; larger measurements are more significant.

The interpretation of TST results varies based on individual risk factors. According to CDC guidelines, a measurement of 5 millimeters or greater may be considered positive for people with HIV, those who have had recent contact with someone with TB, or those with signs of TB disease. For people with lower risk, 10 millimeters or greater is typically the threshold for a positive result. People with no known risk factors need 15 millimeters or greater to be considered positive.

TST advantages include low cost, accessibility at many clinics and doctor's offices, and the ability to test large groups efficiently. However, TST has limitations. Some vaccines, particularly the BCG vaccine used in certain countries, can cause false positive results. Additionally, people with weakened immune systems may have false negative results where TB is present but the test doesn't detect it.

Practical Takeaway: The TST requires two visits to a healthcare facility—one for the injection and one 48 to 72 hours later to read results. Keep your appointment for the reading; results can't be accurately determined by phone or email.

Blood Tests for TB: Interferon-Gamma Release Assays

Interferon-Gamma Release Assays (IGRAs) are modern blood tests that detect TB infection by measuring how the immune system responds to TB bacteria proteins. Common IGRA tests include QuantiFERON-Gold In-Tube (QFT-GIT) and T-SPOT.TB. These tests are based on scientific research showing that people infected with TB have immune cells that produce interferon-gamma when exposed to TB antigens in a test tube.

The process is straightforward: a healthcare provider draws blood into special collection tubes that contain TB antigens. The person can leave after the blood draw—no follow-up appointment is needed. The blood sample is sent to a laboratory where technicians incubate the blood with TB antigens and measure the immune response. Results typically become available within 24 hours to a few days, making IGRAs faster than the TST for many people.

IGRA tests have significant advantages over skin tests. They are not affected by prior BCG vaccination, which makes them particularly useful for people who received this vaccine in other countries. They require only one visit instead of two. Additionally, IGRAs are more specific for TB, meaning they produce fewer false positives in people without TB infection. For these reasons, the CDC now prefers IGRAs in many situations, especially in countries like the United States where TB is less common.

However, IGRAs also have limitations. They cost more than TST, ranging from $75 to $150 depending on location and facility. Like TST, they cannot reliably detect TB in people with severely weakened immune systems, such as those with very low CD4 counts from untreated HIV. Results can also be "indeterminate," meaning the test was not conclusive and may need to be repeated. In rare cases, approximately 5 to 10 percent of tests produce indeterminate results.

Practical Takeaway: Blood tests for TB are faster and require only one visit, but they cost more than skin tests. If you've previously received a BCG vaccine, blood tests avoid false positive results from that vaccine.

Active TB Disease Testing: Sputum and Chest X-rays

When someone has symptoms suggesting active TB disease—such as a persistent cough lasting more than three weeks, chest pain, fever, night sweats, or unexplained weight loss—doctors use different tests to confirm the diagnosis. The most important test is sputum smear microscopy, where a person coughs up mucus and saliva, which is collected in a sterile container. A laboratory technician then examines this sputum under a microscope to look for TB bacteria.

For more accurate diagnosis, sputum can also be cultured, meaning technicians place it in special growth media and watch for TB bacteria to multiply over several weeks. Culture is considered the gold standard for TB diagnosis because it can detect even small amounts of bacteria and can identify which antibiotics will work best. However, cultures take 2 to 8 weeks to produce results, so doctors may start treatment before culture results return if symptoms strongly suggest TB.

Chest X-rays are another critical diagnostic tool for active TB. TB disease, particularly pulmonary TB affecting the lungs, creates characteristic patterns on X-rays. Classic TB often appears as infiltrates (areas of infection) in the upper lobes of the lungs. The appearance can vary depending on the stage of disease and the person's immune status. Chest X-rays provide results quickly, usually within hours, allowing doctors to begin making treatment decisions promptly.

A newer test called GeneXpert MTB/RIF uses molecular technology to detect TB DNA in sputum samples. This test provides results in about two hours and can simultaneously detect resistance to rifampicin, a key TB medication. The World Health Organization recommends GeneXpert as a first-line test in many countries because of its speed and accuracy. In the United States, this test is increasingly available at hospitals and diagnostic centers, though availability varies by location.

Practical Takeaway: If you have persistent cough and fever, ask your doctor about sputum testing and chest X-rays. These tests can identify active TB disease and guide treatment decisions quickly.

Special Testing Situations and Considerations

Different populations require tailored TB testing approaches. For children, skin tests are often preferred because children have difficulty producing sputum samples for testing. Young children with latent TB infection rarely progress to active disease, so preventive treatment is often recommended. Health departments may require TB testing for school enrollment, childcare attendance, or healthcare worker positions, and testing protocols may vary by state and locality.